Free Trial

Myomo 11/6/2024 Earnings Report

Myomo logo
$4.85 +0.04 (+0.83%)
As of 04:10 PM Eastern

Myomo EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.04
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Myomo Revenue Results

Actual Revenue
$9.21 million
Expected Revenue
$7.95 million
Beat/Miss
Beat by +$1.26 million
YoY Revenue Growth
N/A

Myomo Announcement Details

Quarter
Time
After Market Closes
Remove Ads

Myomo Earnings Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
Myomo price target raised to $9.50 from $7.50 at H.C. Wainwright
Q4 2024 Myomo Inc Earnings Call
See More Myomo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Myomo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Myomo and other key companies, straight to your email.

About Myomo

Myomo (NYSEAMERICAN:MYO), a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

View Myomo Profile

More Earnings Resources from MarketBeat